Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma

To evaluate gemcitabine efficacy in advanced pancreatic cancer patients after the FOLFIRINOX regimen. Patients with locally-advanced or metastatic pancreatic adenocarcinoma from French and Canadian centers, who were treated with the first-line FOLFIRINOX regimen (FFX L1), followed by gemcitabine mon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Gilabert, Marine, Chanez, Brice, Rho, Young Soo, Giovanini, Marc, Turrini, Olivier, Batist, Gerald, Kavan, Petr, Raoul, Jean Luc
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2017
Gaiak:
5700
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406057/
https://ncbi.nlm.nih.gov/pubmed/28422841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006544
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak